TCR Based Therapeutics: A Deep Dive in Targets for Cancer IO

This webinar, the eighth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind therapies involving T cell receptors. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target audience of this series.

Moderators:

• Harlan Robins, PhD – Adaptive Biotechnologies Corporation

Faculty:

• David Berman, MD, PhD - Immunocore
• Aude Chapuis, MD - Fred Hutchinson Cancer Center
• Ira Mellman, PhD - Genentech